Clinical Research Support

Regulatory Affairs

Regulatory Affairs provides expertise and support in the conduct of U.S. Food and Drug Administration-regulated human subjects research within the Consortium. The program, working cooperatively with other Center programs, assists investigators performing clinical research under FDA regulations. Regulatory Affairs provides regulatory advice and services to all Consortium member investigators regarding their clinical research, as needed.

The program works with all of Clinical Research Support to ensure that Consortium investigators and their staff are familiar with FDA requirements for Investigational New Drug (IND) applications, Investigational Device Exemptions (IDE), Good Clinical Practices (GCP) and related rules and guidances.

Key Contacts

FDA-Regulated Clinical Research:

Jennifer Davies
Regulatory Affairs Associate

Nelson Spencer
Regulatory Affairs Associate

General Inquiries:

The program provides support to clinical investigators in regulatory activities as well as assisting sponsor-investigators in the preparation and review of regulatory submissions and correspondence with the FDA. These activities include support for Expanded Access INDs (also known as Single-patient, Treatment, or Compassionate Use INDs).

In order to support and facilitate efforts in maintaining compliance with FDA, GCP, DHHS and other federal and state regulatory requirements, Regulatory Affairs works closely with many departments and services throughout the Center, including:

  • Clinical Research Support, including Protocol Review Coordination, Data and Safety Monitoring, internal monitoring and auditing of trials, Quality Assurance, and Training and Education;
  • Institutional Review Offices, including human subjects research and animal care (IRB, IACUC);
  • Environmental Health and Safety (Biosafety and Radiation Safety Committees); and
  • Office of the General Counsel


  • Provide guidance and assistance for preparation and review of regulatory submissions such as initial INDs and IDEs, Expanded Access (single-patient, treatment, compassionate use) INDs, safety reports, annual reports, and other FDA correspondence.
  • Provide support for communications between the Center and the FDA, and/or act as the FDA liaison for sponsor-investigator held INDs or IDEs.
  • Assist with preparation and serve as FDA liaison for FDA inspections of Consortium sponsor-investigator activities.
  • Provide investigators, sponsor-investigators, Clinical Research Support, and others with guidance on regulatory, GCP, and cGMP issues that may arise during conduct of a clinical trial.
  • Interpret and stay current with federal, state and local regulations, policies and trends that affect the Center's clinical research activities, and communicate new information to the relevant departments and individuals.
  • Provide general regulatory advice as needed.

Need Help?

CRS Regulatory Affairs offers weekly office hours for on-the-spot answers to your on-the-fly questions. 

Wondering how to interpret an FDA regulation or guidance?  Need a quick review of regulatory documents or FDA correspondence?  Not sure if your regulatory binders need an overhaul?  RA staff is available nearby for convenient drop-in consultations on Friday mornings:

Fairview Building, room LF-223 9:30 – 10:30 AM 1st and 3rd Fridays of each month
Yale Building, room J1-102      9:30 – 10:30 AM

2nd and 4th Fridays of each month

Individual meetings may be limited to ~15 minutes.  If your question requires further research or additional discussion, we will gladly arrange another time to meet.

Please continue to contact us any time at or by phone at 206-667-1394 (Jenn Davies) or 206-667-7167 (Nelson Spencer).


Menu Search